Haemonetics ($HAE) Insider Trading & Smart Money Activity

Haemonetics Corporation · Medical Devices · Latest filing Oct 15, 2026

Haemonetics Corporation ($HAE) has 1 13F position change and 4 analyst ratings on file.

Insider buyers (12 mo)
0
Insider sellers (12 mo)
0
Net insider $ (12 mo)
$0
Congress trades (12 mo)
0
13F moves on file
1
Analyst ratings on file
4

HAE insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 0 / 0 0 / 0
Q2 2026 0 0 0 / 0 0 / 0
Q3 2026 0 0 0 / 0 0 / 0
Q4 2026 0 0 0 / 0 0 / 1

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All HAE insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
13F Fort Washington Investment Advisors Reduced -379.99K sh $47.48M Read
Analyst BTIG Reiterates to buy PT $84 -2.9%+3.4% Read
Analyst BTIG Reiterates to buy PT $84 +0.2%+7.1% Read
Analyst Mizuho Reiterates to buy PT $85 -5.7%-0.3% Read
Analyst Mizuho Reiterates to buy PT $85 -5.7%-0.3% Read

1W / 1M / 6M = how HAE moved from the trade or filing date.

Institutions moving HAE (13F)

Analyst ratings on HAE

DateFirmActionRatingPrice target1W1M6MStory
BTIG Reiterates buy $84 -2.9%+3.4% Read
BTIG Reiterates buy $84 +0.2%+7.1% Read
Mizuho Reiterates buy $85 -5.7%-0.3% Read
Mizuho Reiterates buy $85 -5.7%-0.3% Read

Frequently asked questions

Which institutions changed their HAE positions?

Recent 13F filers moving the stock include Fort Washington Investment Advisors.

Other medical devices stocks

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text